Inactive Instrument

Highlights Recipharm AB (publ)

Equities

RECI B

SE0005757267

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Blue Wolf Capital Partners LLC agreed to acquire Seven manufacturing and development facilities of Recipharm AB.	Apr. 01	CI
Synokem Pharmaceuticals Limited acquired 74% stake in Nitin Lifesciences Limited from Recipharm AB.	Nov. 27	CI
RS BioTherapeutics Selects Recipharm as Product Characterization Partner	22-11-14	CI
Recipharm AB acquired Arranta Bio Holdings, LLC from Ampersand Capital Partners and others.	22-04-10	CI
Recipharm AB completed the acquisition of Vibalogics GmbH.	22-04-10	CI
Arranta Bio Holdings, LLC agreed to acquire Recipharm AB from Ampersand Capital Partners and others.	22-02-20	CI
Recipharm AB agreed to acquire Vibalogics GmbH.	22-02-17	CI
Recipharm AB acquired GenIBET Biopharmaceuticals, S.A.	22-01-31	CI
Recipharm Secures Vaccine Manufacturing Deal	22-01-27	CI
Recipharm AB agreed to acquire Niche Pharmaceuticals Inc.	22-01-10	CI
Pharmaron Beijing Co., Ltd. acquired Aesica Pharmaceuticals Limited from Recipharm AB.	22-01-09	CI
Recipharm AB Announces First Customer Boards Recipharm's Soft Mist Inhaler Technology Platform	21-09-24	CI
Recipharm Launches New Laboratory to Expand Analytical Services Offering	21-08-24	CI
Recipharm Invests in Fill Finish Capacity	21-07-15	CI
Recipharm : Enters Deal to Operate Fill-Finish Factory in Morocco	21-07-06	MT
Recipharm Signs Memorandum of Understanding for the Fill Finish of Vaccines and Biotherapeutics in Morocco	21-07-06	CI
Moderna, Inc. and Recipharm Site in France Manufacturing Covid-19 Vaccine Moderna Following Approval by European Medicines Agency	21-07-01	CI
EQT IX, managed by EQT Partners AB completed the acquisition of the remaining 74.3% stake in Recipharm AB (OM:RECI B) from AP Fonden 4, Första AP-fonden, AMF Fonder AB, Handelsbanken Asset Management and others.	21-02-28	CI
EQT : Closes Offer Period for Recipharm Acquisition With Over 95% Stake	21-02-15	MT
EQT : Recipharm Takeover Receives European Commission Approval	21-02-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Recipharm AB (publ)

Equities

RECI B

SE0005757267

Highlights

Filters